Injectable PrEP superior to oral PrEP
- PMID: 34453152
- DOI: 10.1038/s41585-021-00515-8
Injectable PrEP superior to oral PrEP
Comment on
-
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.N Engl J Med. 2021 Aug 12;385(7):595-608. doi: 10.1056/NEJMoa2101016. N Engl J Med. 2021. PMID: 34379922 Free PMC article. Clinical Trial.
Similar articles
-
Will Gay and Bisexual Men Taking Oral Pre-exposure Prophylaxis (PrEP) Switch to Long-Acting Injectable PrEP Should It Become Available?AIDS Behav. 2018 Apr;22(4):1184-1189. doi: 10.1007/s10461-017-1907-2. AIDS Behav. 2018. PMID: 28913659 Free PMC article.
-
Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs.J Subst Abuse Treat. 2020 Oct;117:108058. doi: 10.1016/j.jsat.2020.108058. Epub 2020 Jun 15. J Subst Abuse Treat. 2020. PMID: 32811633 Free PMC article.
-
Interest in Long-Acting Injectable PrEP in a Cohort of Men Who have Sex with Men in China.AIDS Behav. 2018 Apr;22(4):1217-1227. doi: 10.1007/s10461-017-1845-z. AIDS Behav. 2018. PMID: 28707025 Free PMC article.
-
Familiarity with and Preferences for Oral and Long-Acting Injectable HIV Pre-exposure Prophylaxis (PrEP) in a National Sample of Gay and Bisexual Men in the U.S.AIDS Behav. 2016 Jul;20(7):1390-9. doi: 10.1007/s10461-016-1370-5. AIDS Behav. 2016. PMID: 27000145 Free PMC article.
-
Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low- and middle-income countries: a systematic review and meta-analysis.J Int AIDS Soc. 2017 Jun 26;20(1):21580. doi: 10.7448/IAS.20.1.21580. J Int AIDS Soc. 2017. PMID: 28691439 Free PMC article. Review.
References
Original article
-
- Landovitz, R. J. et al. Cabotegravir for HIV prevention in cisgender men and transgender women. N. Engl. J. Med. 385, 595–608 (2021) - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous